autoimmune disorders
Immunologic and Anaphylactoid Reactions in Ig Therapy
Immunoglobulin therapy carries the risk for infusion-related reactions that range from mild to life-threatening.
JUNE 17, 2025
Does Lack of Pain Mean Lack of Complications for Patients With Lupus?
Published data indicate that for patients who have lupus, monitoring for kidney disease—even in the absence ...
AUGUST 2, 2024
Fresenius Launches Subcutaneous Formulation of Tyenne, Biosimilar to Tocilizumab
Fresenius, via its operating company Fresenius Kabi, announced the immediate availability in the United States of ...
JULY 10, 2024
Bimekizumab Demonstrates Significant Improvements in Psoriatic Arthritis Joint and Skin Symptoms
Patients taking bimekizumab (UCB Biopharma) experienced a 50% or better improvement in signs and symptoms of ...
NOVEMBER 19, 2021
FDA Approves Saphnelo, First New Treatment for Lupus in 10 Years
This marks the first regulatory approval for a type I interferon receptor antagonist, which plays a central role in ...
AUGUST 4, 2021
